GSA Capital Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.74M Buy
+43,905
New +$3.91M 0.23% 37
2025
Q3
Sell
-2,500
Closed -$227K 1701
2025
Q2
$227K Sell
2,500
-2,863
-53% -$261K 0.02% 1432
2025
Q1
$503K Buy
+5,363
New +$480K 0.05% 798
2024
Q2
Sell
-3,786
Closed -$341K 1668
2024
Q1
$341K Buy
+3,786
New +$321K 0.03% 1135
2023
Q3
Sell
-3,514
Closed -$271K 1538
2023
Q2
$271K Sell
3,514
-324
-8% -$25.1K 0.03% 1107
2023
Q1
$288K Buy
+3,838
New +$285K 0.03% 1052
2022
Q4
Sell
-3,360
Closed -$236K 1514
2022
Q3
$236K Buy
+3,360
New +$263K 0.03% 1095
2021
Q4
Sell
-2,882
Closed -$218K 1447
2021
Q3
$218K Sell
2,882
-536
-16% -$42.6K 0.02% 1194
2021
Q2
$278K Buy
+3,418
New +$279K 0.03% 996
2020
Q2
Sell
-5,445
Closed -$361K 680
2020
Q1
$361K Buy
+5,445
New +$384K 0.09% 357
2019
Q3
Sell
-17,175
Closed -$1.23M 1430
2019
Q2
$1.23M Buy
+17,175
New +$1.22M 0.14% 156
2018
Q2
Sell
-37,582
Closed -$2.69M 1704
2018
Q1
$2.69M Sell
37,582
-5,649
-13% -$407K 0.14% 149
2017
Q4
$3.26M Buy
43,231
+28,628
+196% +$2.09M 0.2% 66
2017
Q3
$1.06M Sell
14,603
-9,082
-38% -$655K 0.07% 487
2017
Q2
$1.76M Buy
+23,685
New +$1.76M 0.11% 208
2017
Q1
Sell
-18,288
Closed -$1.2M 1758
2016
Q4
$1.2M Buy
18,288
+7,208
+65% +$494K 0.07% 462
2016
Q3
$821K Sell
11,080
-37,494
-77% -$2.77M 0.04% 731
2016
Q2
$3.56M Buy
48,574
+38,074
+363% +$2.71M 0.2% 56
2016
Q1
$742K Buy
+10,500
New +$699K 0.05% 732
2015
Q4
Sell
-7,843
Closed -$498K 1824
2015
Q3
$498K Sell
7,843
-23,103
-75% -$1.51M 0.02% 1124
2015
Q2
$2.02M Buy
30,946
+23,546
+318% +$1.6M 0.08% 367
2015
Q1
$513K Sell
7,400
-26,191
-78% -$1.81M 0.02% 1373
2014
Q4
$2.32M Buy
+33,591
New +$2.27M 0.16% 111
2014
Q1
Sell
-5,456
Closed -$356K 1581
2013
Q4
$356K Sell
5,456
-2,544
-32% -$163K 0.03% 1087
2013
Q3
$474K Sell
8,000
-22,392
-74% -$1.33M 0.04% 835
2013
Q2
$1.74M Buy
+30,392
New +$1.8M 0.21% 84

Other funds holding CL

GSA Capital Partners's CL Position: Q1 2026 in Review

GSA Capital Partners opened a new position in Colgate-Palmolive (CL) in Q1 2026: 43,905 shares worth $3.74M. The stake represents 0.23% of the portfolio and ranks #37 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in CL as recently as Q2 2025.

GSA Capital Partners first reported a position in CL in Q2 2013 and has held it in 26 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • GSA Capital Partners held 43,905 shares of Colgate-Palmolive worth $3.74M as of Q1 2026.
  • Colgate-Palmolive was a new GSA Capital Partners position in Q1 2026.
  • Colgate-Palmolive made up 0.23% of GSA Capital Partners's portfolio in Q1 2026, its #37 holding.
  • GSA Capital Partners first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 26 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.